The latest data point for CVS's EPS Surprise % in Q4'25 stands at 9%, indicating a positive but moderated outperformance relative to analyst expectations following a period of volatility. Meanwhile, the EPS Growth (YoY) for the same quarter shows a robust 77.86% increase, reflecting strong year-over-year earnings expansion despite earlier challenges. Over the period from Q1'23 to Q4'25, the EPS Surprise % trend exhibits significant fluctuations, starting with modest positives around 3.8% to 6.3% in 2023, dipping into negatives of -22.9% and -24.3% in Q1'24 and Q3'24, before recovering to highs of 32.4% in Q1'25 and stabilizing above 9% in subsequent quarters, suggesting improving alignment with forecasts amid operational adjustments. In contrast, EPS Growth (YoY) displays high volatility, with sharp declines to -96% in Q3'24 and an extreme -4,571% drop in Q3'25 offset by peaks like 167.7% in Q3'23 and 77.86% in Q4'25, highlighting inconsistent earnings momentum driven by sector-specific pressures and recovery efforts in the healthcare retail space.